Responses of Seropositive Persons to a Single SARS-CoV-2 Vaccine Some persons who
have recovered from Covid-19 have antibodies to the spike protein of SARS-CoV-2. In 43 …

Here, we describe a serological enzyme-linked immunosorbent assay for the screening and
identification of human SARS-CoV-2 seroconverters. This assay does not require the …

COVID-19 mRNA vaccines are highly efficacious in preventing COVID-19 morbidity and
mortality in phase 3 clinical studies as well as in real-world settings. Emerging evidence …

It is concerning that emerging variants of SARS-CoV-2 can evade neutralising antibodies
induced by previous infection or vaccination through mutations in the spike protein, including …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected
millions of people globally. Virus infection requires the receptor-binding domain (RBD) of the …

Background Monkeypox virus has recently infected more than 88 000 people, raising concerns
about our preparedness against this emerging viral pathogen. Licensed and approved …

Zika virus is a mosquito-borne flavivirus closely related to dengue virus that can cause severe
disease in humans, including microcephaly in newborns and Guillain-Barré syndrome in …

N 6 -methyladenosine (m 6 A) is the most abundant HIV RNA modification but the interplay
between the m 6 A reader protein YTHDF3 and HIV replication is not well understood. We …

In 2022 the World Health Organization declared a Public Health Emergency for an outbreak
of mpox, the zoonotic Orthopoxvirus (OPV) affecting at least 104 nonendemic locations …

The stalk of the influenza virus hemagglutinin (HA) is an attractive target for antibody-based
universal influenza virus vaccine development. While antibodies that target this part of the …